match your development and manufacturing path to your IND milestones
De-risk your Early Drug Development
Through Early in silico and in vitro Assessments
Assess, de-risk and optimize for clinical success
In this webinar, we explore the challenges of assessing the immunosafety profile when moving a drug candidate to first-in-human studies.
Complexity solved with high productivity and robust processes with XS Technologies® expression toolbox
